How would you manage a patient with NLPHL and CKD who relapsed after a long disease free interval (i.e. 7 years) following bendamustine?
1 Answers
Mednet Member
Hematology · University of California Irvine
I honestly might consider BR again depending on the counts. I personally use as little as possible - often stopping the B after 3-4 cycles if the patient is in remission.
